Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 4, 2011, Pages 327-334

  Ho, Pak Leung ^a   Chiu, Susan S ^a   Chan, Maggie Y ^a   Ang, Irene ^a   Chow, Kin Hung ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Drug resistance; Prevalence; Serotype; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMICIN PLUS PENICILLIN; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CHILD HEALTH; CONTROLLED STUDY; DISEASE CARRIER; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 82555169636     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.09.006     Document Type: Article

References (31)

1. Ansaldi F., Canepa P., de Florentiis D., Bandettini R., Durando P., Icardi G. Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine. Clin. Vaccine Immunol. 2011, 18:343-345.
2. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., Elvin L., Ensor K.M., Hackell J., Siber G., Malinoski F., Madore D., Chang I., Kohberger R., Watson W., Austrian R., Edwards K. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 2000, 19:187-195.
3. Centers for Disease Control and Prevention Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb. Mortal. Wkly Rep. 2005, 54:893-897.
4. Centers for Disease Control and Prevention Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb. Mortal. Wkly Rep. 2010, 59:253-257.
5. Centers for Disease Control and Prevention Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb. Mortal. Wkly Rep. 2010, 59:258-261.
6. Centre for Health Protection HK (2011a) Inclusion of Pneumococcal Vaccine in Childhood Immunisation Programme Last accessed 25 June 2011.
7. Centre for Health Protection HK (2011b) Safe use of antibiotics save lives. Last accessed 25 June 2011.
8. Chiu S.S., Ho P.L., Chow F.K., Yuen K.Y., Lau Y.L. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob. Agents Chemother. 2001, 45:2765-2770.
9. Choi E.H., Kim S.H., Eun B.W., Kim S.J., Kim N.H., Lee J., Lee H.J. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 2008, 14:275-281.
10. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20 2010, National Committee for Clinical Laboratory Standards, Wayne, PA.
11. Dagan R. New insights on pneumococcal disease: what we have learned over the past decade. Vaccine 2009, 27(Suppl 3):C3-C5.
12. Dagan R. Serotype replacement in perspective. Vaccine 2009, 27(Suppl 3):C22-C24.
13. Hanage W.P., Kaijalainen T.H., Syrjanen R.K., Auranen K., Leinonen M., Makela P.H., Spratt B.G. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect. Immun. 2005, 73:431-435.
14. Hanquet G., Kissling E., Fenoll A., George R., Lepoutre A., Lernout T., Tarrago D., Varon E., Verhaegen J. Pneumococcal serotypes in children in 4 European countries. Emerg. Infect. Dis. 2010, 16:1428-1439.
15. Ho P.L., Ang I., Chow K.H., Lai E.L., Chiu S.S. The prevalence and characteristics of Streptococcus pneumoniae isolates expressing serotypes 6C and 6D in Hong Kong prior to the introduction of the 7-valent pneumococcal conjugate vaccine. Diagn. Microbiol. Infect. Dis. 2010, 68:439-444.
16. Ho P.L., Chiu S.S., Ang I., Lau Y.L. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine 2011, 29:3270-3275.
17. Ho P.L., Chiu S.S., Cheung C.H., Lee R., Tsai T.F., Lau Y.L. Invasive pneumococcal disease burden in Hong Kong children. Pediatr. Infect. Dis. J. 2006, 25:454-455.
18. Ho P.L., Chiu S.S., Chow F.K., Mak G.C., Lau Y.L. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong. Vaccine 2007, 25:6837-6841.
19. Ho P.L., Lam K.F., Chow F.K., Lau Y.L., Wong S.S., Cheng S.L., Chiu S.S. Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children. Vaccine 2004, 22:3334-3339.
20. Ho P.L., Que T.L., Ng T.K., Chiu S.S., Yung R.W., Tsang K.W. Clinical outcomes of bacteremic pneumococcal infections in an area with high resistance. Eur. J. Clin. Microbiol. Infect Dis 2006, 25:323-327.
21. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., Lipsitch M., Hanage W.P., Lee G.M., Finkelstein J.A. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-11.
22. Lam T.P., Ho P.L., Lam K.F., Choi K., Yung R. Use of antibiotics by primary care doctors in Hong Kong. Asia Pac. Fam. Med. 2009, 8:5.
23. Melin M., Trzcinski K., Meri S., Kayhty H., Vakevainen M. The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect. Immun. 2010, 78:5262-5270.
24. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., Gershman K., Reingold A., Farley M., Harrison L.H., Hadler J.L., Bennett N.M., Thomas A.R., Mcgee L., Pilishvili T., Brueggemann A.B., Whitney C.G., Jorgensen J.H., Beall B. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 2008, 197:1016-1027.
25. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 2006, 44:124-131.
26. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Reingold A., Thomas A., Schaffner W., Craig A.S., Smith P.J., Beall B.W., Whitney C.G., Moore M.R. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 2010, 201:32-41.
27. Porat N., Amit U., Givon-Lavi N., Leibovitz E., Dagan R. Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel. Pediatr. Infect. Dis. J. 2010, 29:126-130.
28. Sa-Leao R., Nunes S., Brito-Avo A., Frazao N., Simoes A.S., Crisostomo M.I., Paulo A.C., Saldanha J., Santos-Sanches I., de Lencastre H. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin. Microbiol. Infect. 2009, 15:1002-1007.
29. Shin J., Baek J.Y., Kim S.H., Song J.H., Ko K.S. Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J. Antimicrob. Chemother. 2011, 66:1001-1004.
30. Whitney C.G., Pilishvili T., Farley M.M., Schaffner W., Craig A.S., Lynfield R., Nyquist A.C., Gershman K.A., Vazquez M., Bennett N.M., Reingold A., Thomas A., Glode M.P., Zell E.R., Jorgensen J.H., Beall B., Schuchat A. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368:1495-1502.
31. Yildirim I., Hanage W.P., Lipsitch M., Shea K.M., Stevenson A., Finkelstein J., Huang S.S., Lee G.M., Kleinman K., Pelton S.I. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010, 29:283-288.